Skip to main content

Find Clinical Trials

Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,006 public trials 1,218 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors

NCT00365768

Conditions: Burkitt Lymphoma, Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +55 more
Locations: Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center New York, United States

View Trial Details

Completed

Study to Assess the Safety, Tolerability, and Pharmacokinetics of AMP-224 in Patients With Advanced Cancer

NCT01352884

Conditions: Cancer, Carcinoma, Melanoma, +16 more
Locations: Karmanos Cancer Institute Detroit, Michigan, United States

Memorial Sloan Kettering Cancer Center New York, United States

Carolina BioOncology Institute Huntersville, North Carolina, United States

Sarah Cannon Research Institute Nashville, Tennessee, United States

View Trial Details

Completed

Radiation Therapy and Temozolomide Followed by Temozolomide Plus Sorafenib for Glioblastoma Multiforme

NCT00544817

Conditions: Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +8 more
Locations: Florida Cancer Specialists Fort Myers, Florida, United States

Northeast Georgia Medical Center Gainesville, Georgia, United States

Center for Cancer and Blood Disorders Bethesda, Maryland, United States

Grand Rapids Clinical Oncology Program Grand Rapids, Michigan, United States

View Trial Details

Completed

A Phase I Study of Recombinant hGM-CSF Herpes Simplex Virus to Treat Cancer

NCT01935453

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +25 more
Locations: Beijing Shijitan Hospital,CMU Beijing, Beijing Municipality, China

Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Vandetanib Risk Minimisation Effectiveness

NCT01757470

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +10 more
Locations: Research Site Montreal, Quebec, Canada

View Trial Details

Completed

Clinical and Histological Features of Head and Neck Melanoma

NCT02883933

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Chu de Reims Reims, France

View Trial Details

Completed

Melanoma Risk Assessment & Tailored Intervention

NCT01356771

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations: University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Valproic Acid With Temozolomide and Radiation Therapy to Treat Brain Tumors

NCT00302159

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +16 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

University of Pennsylvania Philadelphia, Pennsylvania, United States

Virginia Commonwealth University Richmond, Virginia, United States

View Trial Details

Completed

Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma

NCT00580320

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoid Tumor, +32 more
Locations: Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States

Massey Cancer Center/Virginia Commonwealth University Richmond, Virginia, United States

View Trial Details

Completed

Trial of Vaccine Therapy With mRNA- Transfected Dendritic Cells in Patients With Advanced Malignant Melanoma

NCT01278940

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: Not specified

View Trial Details